Profile data is unavailable for this security.
About the company
Mochida Pharmaceutical Co Ltd is a Japan-based company principally engaged in the production and sale of drugs. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The Company also conducts brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.
- Revenue in JPY (TTM)103.26bn
- Net income in JPY6.65bn
- Incorporated1945
- Employees1.54k
- LocationMochida Pharmaceutical Co Ltd1-1, Ichigayahommura-choSHINJUKU-KU 162-0845JapanJPN
- Phone+81 333587211
- Fax+81 333587887
- Websitehttps://www.mochida.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eiken Chemical Co Ltd | 43.27bn | 5.74bn | 65.44bn | 745.00 | 9.77 | 1.12 | 8.32 | 1.51 | 153.90 | 153.90 | 1,160.64 | 1,337.74 | 0.672 | 2.74 | 3.75 | -- | 8.91 | 8.83 | 11.05 | 11.34 | 47.39 | 46.39 | 13.26 | 12.16 | 2.48 | -- | 0.08 | 31.28 | 0.6396 | 4.34 | -7.75 | 17.07 | 0.6216 | 15.33 |
| Towa Pharmaceutical Co Ltd | 208.86bn | 2.20bn | 90.87bn | 4.08k | 40.01 | 0.6343 | 4.21 | 0.4351 | 44.09 | 44.09 | 4,219.21 | 2,781.16 | 0.5938 | 1.64 | 3.97 | -- | 0.6258 | 4.73 | 0.8634 | 6.39 | 34.81 | 41.27 | 1.05 | 8.06 | 1.15 | -- | 0.5413 | 19.74 | 26.11 | 17.46 | -86.17 | -19.46 | 14.66 | 13.63 |
| Shin Nippon Biomedical Laboratories Ltd | 25.09bn | 6.06bn | 99.04bn | 994.00 | 16.34 | 3.78 | 12.94 | 3.95 | 145.57 | 145.57 | 602.69 | 629.61 | 0.5197 | 2.06 | 6.12 | -- | 12.53 | 9.47 | 19.56 | 14.34 | 52.00 | 50.00 | 24.12 | 24.39 | 0.7886 | -- | 0.4158 | 19.11 | 41.37 | 8.61 | -14.98 | -- | 37.23 | -- |
| Torii Pharmaceutical Co Ltd | 49.75bn | 2.77bn | 99.50bn | 563.00 | 34.99 | 0.8293 | 30.77 | 2.00 | 98.73 | 98.73 | 1,770.51 | 4,166.29 | 0.3843 | 2.64 | 2.30 | 88,360,570.00 | 2.14 | 6.35 | 2.34 | 7.24 | 47.47 | 50.37 | 5.57 | 16.18 | 6.68 | -- | 0.00 | 20.83 | 4.06 | -5.28 | 16.89 | -3.52 | -18.66 | 15.81 |
| Kyorin Pharmaceutical Co Ltd | 113.27bn | 4.72bn | 114.55bn | 2.22k | 21.51 | 0.8098 | 13.38 | 1.01 | 82.42 | 82.42 | 1,976.68 | 2,189.40 | 0.651 | 1.40 | 2.65 | -- | 2.72 | 3.20 | 3.36 | 3.93 | 44.29 | 48.72 | 4.17 | 5.10 | 2.03 | -- | 0.145 | 67.80 | 7.33 | 0.471 | 20.12 | -6.40 | 19.42 | -2.16 |
| Zeria Pharmaceutical Co Ltd | 68.38bn | 6.20bn | 126.85bn | 1.74k | 17.04 | 1.61 | 10.27 | 1.85 | 140.14 | 140.14 | 1,548.07 | 1,484.79 | 0.5274 | 1.53 | 4.14 | -- | 4.79 | 3.37 | 7.41 | 5.40 | 72.37 | 71.45 | 9.08 | 6.52 | 0.7515 | 6.27 | 0.4294 | 41.03 | 14.87 | 1.15 | 56.41 | 8.30 | 5.40 | 3.30 |
| Mochida Pharmaceutical Co Ltd | 103.26bn | 6.65bn | 129.36bn | 1.54k | 18.90 | 0.9683 | 13.88 | 1.25 | 177.78 | 177.78 | 2,778.76 | 3,470.18 | 0.6414 | 2.03 | 3.47 | -- | 4.13 | 4.86 | 5.02 | 5.94 | 53.37 | 52.20 | 6.44 | 7.36 | 3.41 | -- | -- | 41.67 | -6.28 | -0.6644 | -37.09 | -5.92 | 14.62 | -1.21 |
| ispace Inc | 989.24m | -11.40bn | 132.38bn | 220.00 | -- | -- | -- | 133.82 | -211.47 | -211.47 | 18.35 | -43.55 | -- | -- | -- | -- | -- | -- | -- | -- | 55.88 | -- | -1,152.22 | -- | 1.36 | -97.84 | 1.53 | -- | 46.74 | -- | -180.75 | -- | -- | -- |
| Sawai Group Holdings Co Ltd | 200.34bn | 12.67bn | 144.73bn | 2.97k | 11.45 | 0.7178 | 4.74 | 0.7224 | 288.73 | 288.73 | 4,567.63 | 4,604.67 | 0.5615 | 1.47 | 3.03 | -- | 3.60 | 1.14 | 4.95 | 1.56 | 31.26 | 36.92 | 6.41 | 2.24 | 1.22 | 87.95 | 0.2558 | 80.41 | 3.37 | 3.58 | 144.81 | -2.01 | 10.06 | 0.00 |
| Kissei Pharmaceutical Co Ltd | 67.49bn | 10.53bn | 148.49bn | 1.83k | 12.55 | 0.6816 | 10.07 | 2.20 | 228.30 | 228.30 | 1,463.58 | 4,204.65 | 0.2939 | 1.68 | 2.96 | -- | 4.63 | 3.21 | 5.02 | 3.47 | 47.97 | 52.39 | 15.76 | 11.10 | 5.20 | -- | 0.0076 | 36.53 | 3.23 | -1.83 | -18.52 | 3.08 | 3.74 | 10.76 |
| KAKEN PHARMACEUTICAL CO., LTD. | 72.98bn | 5.44bn | 164.69bn | 1.16k | 24.83 | 0.9859 | 20.57 | 2.26 | 144.37 | 144.37 | 1,942.57 | 3,636.17 | 0.4403 | 2.19 | 3.69 | -- | 3.28 | 8.17 | 3.75 | 9.56 | 54.20 | 55.55 | 7.45 | 16.09 | 4.53 | -- | 0.0274 | 44.00 | -4.01 | -5.81 | -43.03 | -22.17 | 3.16 | 0.00 |
| JCR Pharmaceuticals Co Ltd | 34.34bn | 3.77bn | 182.99bn | 816.00 | 46.78 | 3.38 | 31.64 | 5.33 | 30.16 | 30.16 | 275.36 | 418.05 | 0.3576 | 0.5361 | 2.57 | -- | 3.94 | 9.63 | 6.66 | 14.67 | 74.13 | 74.34 | 11.03 | 19.32 | 0.819 | -- | 0.3031 | 26.30 | -32.77 | 10.77 | -74.00 | 4.20 | 53.67 | 25.21 |
Data as of Jun 02 2023. Currency figures normalised to Mochida Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
9.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 28 Apr 2023 | 715.20k | 1.86% |
| The Vanguard Group, Inc.as of 05 May 2023 | 659.42k | 1.71% |
| Asset Management One Co., Ltd.as of 30 Sep 2022 | 587.00k | 1.53% |
| BlackRock Fund Advisorsas of 04 May 2023 | 345.10k | 0.90% |
| Daiwa Asset Management Co. Ltd.as of 28 Apr 2023 | 329.90k | 0.86% |
| Nikko Asset Management Co., Ltd.as of 02 May 2023 | 320.10k | 0.83% |
| Norges Bank Investment Managementas of 31 Dec 2022 | 238.86k | 0.62% |
| Dimensional Fund Advisors LPas of 04 May 2023 | 167.00k | 0.43% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 31 Oct 2022 | 147.10k | 0.38% |
| Charles Schwab Investment Management, Inc.as of 04 May 2023 | 101.72k | 0.26% |
More ▼
Data from 31 Dec 2022 - 31 Mar 2023Source: FactSet Research Systems Inc.
